Video | 04 April 2022 Why we’re asking governments to reject the leaked text on COVID-19 at the WTO COVID-19 Leena Menghaney outlines why the leaked TRIPS Waiver doesn't go anywhere near far enough in terms of addressing the development of COVID-19 treatments, vaccines and diagnostics. Read, watch, share Filter by - Any -BlogEventsExplainerFeature storyInterviewIssue briefLetterNewsletterOpinion articlePress releaseSpeechSpotlightStatementTechnical briefVideo Photograph by Barbara Pardo Press release Press release | 06 June 2022 COVID-19 MSF to governments negotiating at WTO: get it right and adopt the real TRIPS Waiver 3 min Photograph by Max Cabello Oorcasitas Press release Press release | 31 May 2022 COVID-19 German government must push BioNTech to urgently transfer mRNA vaccine technology 4 min Letter | 31 May 2022 COVID-19 United Kingdom Joint UK CSO letter to the UK government on TRIPS waiver negotiations and flawed CSO consultation process Events Events Research and development Roundtable series: How can disclosing clinical trial costs increase access to medical products 2 min Blog Blog | 17 May 2022 COVID-19 Patently unfair: when climate justice aligns with access to medicines Newsletter Newsletter | 05 May 2022 COVID-19 Reject the FLAWED COVID proposal at WTO for equitable access to medical tools Blog Blog | 04 May 2022 COVID-19 Draft COVID-19 proposal at WTO may not resolve inequitable access to medicines Newsletter Newsletter | 28 April 2022 COVID-19 Share vaccine tech! Prepare for the future! Load More
Photograph by Barbara Pardo Press release Press release | 06 June 2022 COVID-19 MSF to governments negotiating at WTO: get it right and adopt the real TRIPS Waiver 3 min
Photograph by Max Cabello Oorcasitas Press release Press release | 31 May 2022 COVID-19 German government must push BioNTech to urgently transfer mRNA vaccine technology 4 min
Letter | 31 May 2022 COVID-19 United Kingdom Joint UK CSO letter to the UK government on TRIPS waiver negotiations and flawed CSO consultation process
Events Events Research and development Roundtable series: How can disclosing clinical trial costs increase access to medical products 2 min
Blog Blog | 17 May 2022 COVID-19 Patently unfair: when climate justice aligns with access to medicines
Newsletter Newsletter | 05 May 2022 COVID-19 Reject the FLAWED COVID proposal at WTO for equitable access to medical tools
Blog Blog | 04 May 2022 COVID-19 Draft COVID-19 proposal at WTO may not resolve inequitable access to medicines
